TrialNeurosurgery2015

Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) Trial.

Carole L Turner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.